홈
탐색
nav.journalClub
트렌드
더보기
synapse
⌘+K
언어
한국어
한국어
Pharmacometrics insights into major bleeding risk in rivaroxaban-treated atrial fibrillation patients | Synapse
May 11, 2026
Pharmacometrics insights into major bleeding risk in rivaroxaban-treated atrial fibrillation patients
WT
W.T. Tang
DY
D.T.W. Yong
SG
S.M. Sheikh Ghadzi
See all
Key Points
Key points are not available for this paper at this time.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Tang et al. (Fri,) studied this question.
synapsesocial.com/papers/6a025f0cc9581ed855361be1
https://doi.org/https://doi.org/10.1016/j.ijcard.2026.134331
Mark Helpful
Like
Save
Bookmark
Relay
Share